Endo International plc Research and Development in Process
Endo International plc reported Research and Development in Process of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-05-08
- Endo International plc research and development in process for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Endo International plc research and development in process for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Endo International plc research and development in process for the quarter ending 2022-09-30 was $800.00K.
- Endo International plc research and development in process for the quarter ending 2022-06-30 was $65.00M, a 1200.00% increase year-over-year.
- Endo International plc research and development in process for fiscal 2022 was $68.70M, a 173.49% increase from fiscal 2021.
- Endo International plc research and development in process for fiscal 2021 was $25.12M, a 24.63% decline from fiscal 2020.
- Endo International plc research and development in process for fiscal 2020 was $33.33M.
- Endo International plc research and development in process for fiscal 2019 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month | Research and Development in Process 12 month as first filed |
|---|---|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2023-05-08 | $800.00K derived: sum of 3 quarters · filed 2023-05-08 | $65.80M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $800.00K derived: sum of 2 quarters · filed 2023-03-06 | $65.80M derived: sum of 3 quarters · filed 2023-03-06 | $68.70M 10-K · filed 2023-03-06 | |
| 2022-09-30 | $800.00K 10-Q · filed 2022-11-09 | $65.80M derived: sum of 2 quarters · filed 2022-11-09 | $68.70M 10-Q · filed 2022-11-09 | $88.82M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2022-06-30 | $65.00M 10-Q · filed 2022-08-09 | $67.90M 10-Q · filed 2022-08-09 | $88.02M derived: sum of 3 quarters · filed 2023-05-08 | $88.02M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2022-03-31 | $2.90M 10-Q · filed 2023-05-08 | $23.02M derived: sum of 2 quarters · filed 2023-05-08 | $23.02M derived: sum of 3 quarters · filed 2023-05-08 | $28.02M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $20.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $20.12M derived: sum of 2 quarters · filed 2023-03-06 | $25.12M derived: sum of 3 quarters · filed 2023-03-06 | $25.12M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $5.00M derived: sum of 2 quarters · filed 2022-11-09 | $5.00M 10-Q · filed 2022-11-09 | $38.33M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $5.00M 10-Q · filed 2022-08-09 | $5.00M 10-Q · filed 2022-08-09 | $38.33M derived: sum of 3 quarters · filed 2023-03-06 | $38.33M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | $33.33M derived: sum of 2 quarters · filed 2023-03-06 | $33.33M derived: sum of 3 quarters · filed 2023-03-06 | ||
| 2020-12-31 | $33.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $33.33M derived: sum of 2 quarters · filed 2023-03-06 | $33.33M 10-K · filed 2023-03-06 | $28.60M 10-K · filed 2021-02-26 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |